Title : Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy.

Pub. Date : 2019 Jan 1

PMID : 30403784






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Conclusions: Consequently, fluoroquinolones/metronidazole/clarithromycin-based triple therapies can be used to eradicate H. pylori infection, if one does not know the CYP2C19 genotype of the patient. Clarithromycin cytochrome P450 family 2 subfamily C member 19 Homo sapiens